INTEGRATED BIOPHARMA INC Proceeds from Notes Payable
INTEGRATED BIOPHARMA INC (INBP) reported Proceeds from Notes Payable of $1.64 million for the 12-month period ending 2020-06-30, per its 10-K filed 2021-09-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2021-09-02
- INTEGRATED BIOPHARMA INC proceeds from notes payable for the quarter ending 2016-06-30 was $0.00.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for the quarter ending 2011-06-30 was $0.00.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for the quarter ending 2011-03-31 was $0.00.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for the quarter ending 2010-12-31 was $0.00.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for fiscal 2020 was $1.64M, a 31.71% decline from fiscal 2019.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for fiscal 2019 was $2.40M.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for fiscal 2016 was $1.98M.
- INTEGRATED BIOPHARMA INC proceeds from notes payable for fiscal 2012 was $3.77M, a 9320.00% increase from fiscal 2011.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2020-06-30 | $1.64M 10-K · filed 2021-09-02 | |||
| 2019-06-30 | $2.40M 10-K · filed 2020-09-23 | |||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | $1.98M 10-K · filed 2017-09-01 | ||
| 2016-03-31 | $1.98M 10-Q · filed 2017-05-10 | |||
| 2012-06-30 | $3.77M 10-K · filed 2013-09-30 | |||
| 2011-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-10-15 | $0.00 derived: sum of 2 quarters · filed 2012-10-15 | $0.00 derived: sum of 3 quarters · filed 2012-10-15 | $40.00K 10-K · filed 2012-10-15 |
| 2011-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-21 | $0.00 derived: sum of 2 quarters · filed 2012-05-21 | $40.00K 10-Q · filed 2012-05-21 | |
| 2010-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-21 | $40.00K 10-Q · filed 2012-02-21 | ||
| 2010-09-30 | $40.00K 10-Q · filed 2011-11-21 |